• The Analytical R&D team consists of scientists with expertise in areas of method development, method validations and superior analytical, evaluative and problem-solving abilities.
  • The state-of-the-art equipments in place include HPLCs, GCs, Dissolution, UV-VIS spectrophotometer and UPLC's with various modes of detection.

Key focus of the Analytical R&D is to develop and validate methods for:

  • Raw material testing
  • Active pharmaceutical ingredients
  • Intermediates for chromatographic purity and assay
  • In-process control
  • Chiral analysis
  • cResidual solvents
  • Cleaning verification/validation
  • Finished dosage forms like tablets, capsules and parenterals
  • Formulation development for Trial batches.
  • Method transfers and validation are performed according to the GMP procedures and approved protocols.
  • ICH stability studies are performed on drug substances and /or dosage forms according to the Stability Study Protocols and GMP standards.